Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

CAN-10 shows promise in systemic sclerosis model

Dec. 15, 2021

Roche divulges new cGAS inhibitors

Dec. 13, 2021

Bristol Myers Squibb synthesizes new galectin-3 inhibitors

Dec. 3, 2021

Stepwise engineered IL-37-Fc-fusion protein shows improved therapeutic likeness

Dec. 2, 2021

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Emultech and Osteo-Pharma establish Bone-Tech joint venture for osteoarthritis

Nov. 18, 2021

Researchers unveil CCN1 as a therapeutic target for rheumatoid arthritis

Nov. 17, 2021

Enhancing endothelial cell S1PR1 signaling attenuates arthritis in vivo

Nov. 16, 2021

Targeting NNMT as novel therapeutic strategy for fibrotic diseases

Nov. 16, 2021

Takinib inhibits STAT3 activation and shows promise for treating rheumatoid arthritis

Nov. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...